icd10free.comPowered by Curo

ICD-10 Coding for Elevated CA-125(R97.1, R97.8)

Save

Learn about the ICD-10 coding for elevated CA-125, including documentation requirements, coding pitfalls, and billing considerations.

Also known as:
Elevated Carcinoma Antigen 125High CA-125 Levels
Related ICD-10 Code Ranges

Complete code families applicable to Elevated CA-125

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
R97.1Elevated cancer antigen 125 [CA 125]
C56Malignant neoplasm of ovary
Primary ICD-10-CM Codes
Elevated cancer antigen 125 [CA 125]
R97.1Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Other abnormal tumor markersR97.8

Documentation & Coding Risks

Avoid these common issues when documenting Elevated CA-125.

Omitting clinical context for elevated CA-125

Impact

Clinical: May lead to misinterpretation of lab results., Regulatory: Increases risk of audit due to incomplete documentation., Financial: Potential for denied claims due to lack of supporting documentation.

Mitigation

Always include clinical context in documentation., Ensure lab results are accompanied by relevant clinical findings.

Using R97.1 as primary code for active ovarian cancer treatment

Impact

Reimbursement: Incorrect sequencing can lead to reduced reimbursement., Compliance: May trigger audits for incorrect coding., Data Quality: Affects accuracy of patient records and data reporting.

Mitigation

Sequence C56 as primary and R97.1 as secondary.

Incorrect sequencing of codes

Impact

Using R97.1 as primary code when malignancy is present.

Mitigation

Educate coders on proper sequencing rules and provide regular audits.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with R97.1.